Rifampin
Capsule
Current
FDA shortage record
- Substance
- Rifampin
- Manufacturer
- Lupin Pharmaceuticals, Inc.
- Dosage form
- Capsule
- Presentation
- Rifampin, Capsule, 150 mg (NDC 68180-658-06)
- Route(s)
- ORAL
- Therapeutic category
- Anti-Infective
- Package NDC
68180-658-06- Initially posted
- 12/22/2021
- Current FDA status
- Current
Reason and context
Reason reported: Shortage of an active ingredient
On allocation
Manufacturer contact
Per the FDA record, the manufacturer's contact for supply inquiries is 866-587-4617.
If you're affected by this shortage
- Talk to your prescribing clinician or pharmacist about therapeutic alternatives. Do not switch medications on your own.
- Ask your pharmacy to check supply across multiple wholesalers and other branches.
- Check current pharmacy pricing and availability via GoodRx (affiliate link).
- Report a continuing supply problem to FDA via the FDA Drug Shortages contact form.
Sources
- FDA Drug Shortages database, accessed via the openFDA Drug Shortages API.
- FDA Structured Product Label (SPL set ID
b56004f0-f23d-47f6-80c7-39884fccbccc). - FDA UNII identifier:
VJT6J7R4TR. - See the Drug Shortage Tracker methodology for sourcing, update cadence, normalization rules, and limits.
Important
This page reproduces publicly available FDA shortage data for informational purposes only. It is not medical advice and does not establish a clinician-patient relationship. Shortage status changes frequently; verify directly with your pharmacist or the FDA Drug Shortages site before making any treatment decision.